The metasediments in the Chamba region experienced three phases of deformation: DF 1 , DF 2 and DF 3. Folded quartz veins are co-folded with the F 2 crenulation folds. Their geometric and tectonic significance is studied by microstructures and shortening adjacent to the discrete crenulation cleavage, S 2. Microstructures of folded vein segments, their geometric changes and truncation to cleavage (S 2) are mainly due to pressure-solution phenomena and the estimated volume loss from reconstructed vein segments range from 16 to 25.5%, which is closely related to volume decrease (26%) calculated from the polydeformed slates of North Wales areas.
First phase folds F 1 developed in polydeformed Ajabgarh Group rocks of Proterozoic age are studied using various geometrical methods of analysis for compatibility of homogeneous strain in both class 1-3 pairs by correlating t α /α plots with existing curves for competent layers and matching t α /α plots with the flattening curves for the incompetent layers. F 1 folds were initiated by the process of buckling but underwent [(λ 2 /λ 1) = 0.2 to 0.7] for competent layers and R-values of 1.1 to 5 for incompetent layers. The varying flattening is also revealed by the geometry of folds. The apparent buckle shortening of folds which ranges between 49 and 67 per cent with a majority of the folds having shortening values between 50% and 55% (exclusive of layer parallel strain) and inverse thickness method strain up to 50%. Besides flattening, the fold geometry was also modified by the pressure solution. This is borne by the presence of dark seams rich in phyllosilicates and disseminated carbonaceous material offsetting limbs of buckled quartz veins in slates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.